Rob Forsyth

[Rob Forsyth @RobJForsyth]

Content-aware measures of rehabilitation dose are robustly causally related to pertinent aspects of outcome. These findings are step toward a goal of comparative effectiveness research in pediatric neurorehabilitation (3/3)

[Rob Forsyth @RobJForsyth]

Improving the evidence base for neurorehabilitation in paediatric acquired brain injury is challenging. Both rehab content and outcomes after ABI are multifaceted. But paying attention to rehab content yields insights (2/3)

[Rob Forsyth @RobJForsyth]

@rehabresearchuk @NeuroNCL @Childrens_Trust @BPNA_org New paper https://t.co/R70IHcbJJG Demonstration of functional rehabilitation treatment effects in children and young people after severe acquired brain injury (1/3)

[CRESCENT Trial @CRESCENTtrial]

@epilepsyaction Please RT. Keen to speak with parents with experience of #status epilepticus in their child for any reason. CRESCENT is a clinical trial of a new treatment for #status, opening spring 2022 (1/3)

[CRESCENT Trial @CRESCENTtrial]

A superb initial response from UK Paed EDs to CRESCENT: double blind RCT of 100% oxygen vs 95% O2: 5% CO2 for first 10 mins alongside standard APLS management of #status epilepticus. (1/3)

[Rob Forsyth @RobJForsyth]

@pg_onthemove https://t.co/jt1u9vW3xM

[Rob Forsyth @RobJForsyth]

@thesiswhisperer @jasondowns As the “sadly anonymous” (= dim!) listener who forgot to leave his name on the original speak pipe message — enjoyed this!

[Sacha Altay @Sacha_Altay]

April fool’s day sends the wrong message.

Being a critical thinker is *not* being skeptical of everything. And critical thinking is *not* only about content but also, and mostly, about the source.

[CRESCENT Trial @CRESCENTtrial]

Learn more and register your interest in being a participating site at https://t.co/z4BWrlzSBO by end of May 2021 (4/4)

[CRESCENT Trial @CRESCENTtrial]

CRESCENT is a double blind RCT comparing inhalation of 100% oxygen vs 95% O2: 5% CO2 for first 10 mins alongside standard APLS management of #status epilepticus. Deferred consent model and outcome collection complete at 24h (3/4)

[CRESCENT Trial @CRESCENTtrial]

Especially in children, brain pH manipulation may be an important, under-estimated means of terminating seizures avoiding respiratory depression and with potential for pre-hospital use (2/4)

[CRESCENT Trial @CRESCENTtrial]

Calling research-active UK Paed Emergency Departments! CRESCENT builds on the success of #EcLiPSE working with #PERUKI to deliver an RCT of a novel treatment for #status epilepticus in children @PERUKItweep @mullen_niall @Damian_Roland @mdlyttle @livuni_LCTC @NIHRresearch (1/4)

[Rob Forsyth @RobJForsyth]

@dricjohnstone Need to get back there!

[Rob Forsyth @RobJForsyth]

@peternealtaylor Yes huge congratulations Peter. Richly deserved

[Rob Forsyth @RobJForsyth]

Like Humans, Crows Can “Ponder the Content of Their Own Minds” https://t.co/b28Rqe8Uay

[Rob Forsyth @RobJForsyth]

@danielnettle Will this be recorded Daniel?

[Neurology Journal @GreenJournal]

Early deviation from normal structural connectivity
A novel intrinsic severity score for mild TBI https://t.co/JoiyYxhdql #Neurology

[Prof Ian Donald @professoriandonald.bsky.social @iandonald_psych]

1. The govt strategy on #Coronavirus is more refined than those used in other countries and potentially very effective. But it is also riskier and based on a number of assumptions. They need to be correct, and the measures they introduce need to work when they are supposed to.

[Rob Forsyth @RobJForsyth]

@patyrossini Hi Patricia — was expecting to Skype this morning. Still on?

[Rob Forsyth @RobJForsyth]

@patyrossini Hi Dr Rossini I have an emailed your Liverpool address asking if you can participate in a masterclass in Cambridge Sept 2020 just checking you’ve seen this? Thx